Table 2.
Saikosaponins | Therapy | Mode of action | Target molecules | Cancer model | Ref. |
---|---|---|---|---|---|
SSa | DOX, VCR, PAC | Apoptosis | P-gp | MDR breast & liver cancer | [32] |
CDDP | Apoptosis | ROS | Cervical & ovarian & lung cancer | [35] | |
SSb | ET | Apoptosis, DNA damage | NF-κB | Melanoma | [37] |
SSd | DOX | Cytotoxicity | P-gp | MDR breast cancer | [33] |
DOX | Cytotoxicity | P-gp | MDR breast cancer | [34] | |
CDDP | Apoptosis | ROS | Cervical & ovarian & lung cancer | [35] | |
TNF-α | Apoptosis | NF-κB | Cervical & liver cancer | [36] | |
IR | G1 phase arrest, apoptosis | p53, Bax, Bcl-2 | Liver cancer | [38] | |
IR | Apoptosis | HIF-1α, p53, Bax, Bcl-2 | Liver cancer | [39] | |
IR | DNA damage | GSH, MDA | Liver cancer | [40] |